Matthew T. Wiley, Chief Commercial Officer at Foamix Pharmaceuticals Ltd. (FOMX), bought 26,880 shares at $3.76 ($101K) on 2019-03-05, disclosed to the SEC on 2019-03-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.76 | 13,440 | $51K | 50.0% |
| 2 | $3.76 | 13,440 | $51K | 50.0% |
| Total | $3.76 avg | 26,880 | $101K | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $148 | — | Filing → |
| BTAI | SELL | 2024-06-18 | $307 | — | Filing → |
| BTAI | SELL | 2024-04-08 | $3K | — | Filing → |